| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows From Operating Activities | ||||||||||||
Net loss | ||||||||||||
-20,675 | -21,156 | -22,098 | -21,770 | -19,755 | -17,253 | -13,232 | -9,795 | -7,453 | -5,129 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||
Depreciation and amortization | ||||||||||||
41 | 15 | 10 | 12 | 16 | 19 | 29 | 23 | 23 | 25 | 0 | 0 | 0 |
Stock-based compensation | ||||||||||||
2,062 | 2,511 | 2,434 | 2,420 | 1,997 | 1,615 | 1,314 | 1,058 | 1,059 | 412 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | ||||||||||||
Prepaid expenses and other current assets | ||||||||||||
-174 | 63 | 98 | 326 | 202 | 95 | 163 | 225 | 340 | 34 | 0 | 0 | 0 |
Accounts payable | ||||||||||||
-808 | 31 | 755 | 1,002 | 1,511 | 1,263 | 518 | 192 | -86 | -55 | 0 | 0 | 0 |
Accrued compensation | ||||||||||||
-69 | 4 | 591 | 437 | 417 | 912 | 0 | 0 | 0 | - | - | - | - |
Accrued expenses and other current liabilities | ||||||||||||
331 | -266 | -642 | -424 | -527 | 503 | 649 | 497 | 543 | 51 | 0 | 0 | 0 |
Deferred rent | ||||||||||||
2 | 3 | 43 | 44 | 43 | 41 | 0 | 0 | 0 | - | - | - | - |
Net Cash Used In Operating Activities | ||||||||||||
-18,940 | -18,919 | -19,004 | -18,720 | -16,616 | -13,111 | -10,998 | -8,249 | -6,253 | -4,731 | 0 | 0 | 0 |
Cash Flows From Investing Activities | ||||||||||||
Purchases of property and equipment | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | 10 | 0 | 0 | 0 |
Net Cash Used In Investing Activities | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | -10 | 0 | 0 | 0 |
Cash Flows From Financing Activities | ||||||||||||
Proceeds from sale of units in private placement | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Repayment of short-term note payable | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Payment of private placement issuance costs | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Payment of initial public offering issuance costs | ||||||||||||
- | - | - | - | - | 345 | 459 | 541 | 541 | 195 | 0 | 0 | 0 |
Proceeds from sale of common stock in public offering | ||||||||||||
- | - | - | - | - | 0 | 0 | 25,089 | 25,089 | 0 | 0 | 0 | 0 |
Proceeds from exercise of stock options | ||||||||||||
67 | 551 | 551 | 608 | 540 | 56 | 0 | 0 | 0 | - | - | - | - |
Net Cash Provided By Financing Activities | ||||||||||||
18,541 | 13,510 | 16,328 | 3,426 | 3,358 | 27,617 | 24,643 | 31,347 | 31,347 | 6,603 | 0 | 0 | 0 |
Net Decrease in Cash | ||||||||||||
-659 | -5,575 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Supplemental Disclosure of Cash Flow Information: | ||||||||||||
Interest expense | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Income taxes | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Net (Decrease) Increase in Cash and Cash Equivalents | ||||||||||||
- | - | - | - | - | - | - | - | 25,095 | 1,862 | 0 | 0 | 0 |
Supplemental Disclosure of Non-Cash Investing and Financing Activities | ||||||||||||
Accrual of private placement offering costs | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Purchase of insurance premium financed by short-term note payable | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Exercise of warrants on a cashless basis | ||||||||||||
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
Conversion of convertible preferred stock into common stock | ||||||||||||
- | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reversal of previously accrued initial public offering issuance costs | ||||||||||||
- | - | - | - | - | -133 | -133 | -133 | -133 | 0 | 0 | 0 | 0 |
Reduction of additional paid-in capital for initial public offering issuance costs that were previously paid | ||||||||||||
- | - | - | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 |